References of "Boverie, S."
     in
Bookmark and Share    
Peer Reviewed
See detailDevelopment of 4H-1,2,4-benzothiadiazine 1,1-dioxides as putative tocolytic agents: pharmacological evaluation on different smooth muscle preparations
Boverie, S.; Becker, B.; Sebille, S. et al

Poster (2002, March 02)

Detailed reference viewed: 2 (0 ULg)
Full Text
Peer Reviewed
See detail3-R/S-(hydroxyalkylamino)-4H-1,2,4-benzothiadiazine 1,1-dioxides as potential K+ATP channel activators: influence of stereochemistry on biological activity and tissue selectivity
Boverie, S.; Becker, B.; Somers, F. et al

in Fundamental & Clinical Pharmacology (2002)

Detailed reference viewed: 11 (2 ULg)
Full Text
Peer Reviewed
See detailPharmacological evaluation of cromakalim analogues: towards the discovery of new inhibitors of insulin secretion from rat pancreatic Beta-cells
Sebille, S.; becker, B.; Antoine, M. H. et al

in Fundamental & Clinical Pharmacology (2002)

Detailed reference viewed: 7 (3 ULg)
Full Text
Peer Reviewed
See detaildevelopment of 4H-1,2,4-benzothiadiazine 1,1-dioxides as putative tocolytic agents: pharmacological evaluation on diferent smooth muscle preparations
Boverie, S.; Becker, B.; Sebille, S. et al

in Fundamental & Clinical Pharmacology (2002)

Detailed reference viewed: 6 (1 ULg)
Full Text
Peer Reviewed
See detailPharmacological evaluation of cromakalim analogues: towards the discovery of new inhibitors of insulin secretion from rat pancreatic Beta-cells
Sebille, S.; Becker, B.; Antoine, M. H. et al

in Fundamental & Clinical Pharmacology (2002)

Detailed reference viewed: 6 (1 ULg)
Full Text
Peer Reviewed
See detailPharmacological evaluation of cromakalim analogues: towards the discovery of new inhibitors of insulin secretion from rat pancreatic -cells
Sebille, S.; Becker, B.; Antoine, M. H. et al

in Fundamental & Clinical Pharmacology (2002)

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailDevelopment of 4H-1,2,4-benzothiadiazine 1,1-dioxides as putative tocolytic agents: pharmacological evaluation on different smooth muscle preparations
Becker, B.; Sebille, S.; Antoine, M. H. et al

in Fundamental & Clinical Pharmacology (2002)

Detailed reference viewed: 7 (0 ULg)
Full Text
Peer Reviewed
See detailRelaxant effect of K+ATP channel openers on the uterine smooth muscle; phrmacological in vitro models
De Tullio, Pascal ULg; Boverie, S.; Dewalque, D. et al

in Fundamental & Clinical Pharmacology (2002)

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detail2-N-alkylation of 3-alkylamino-substituted 2H-benzo- and 2H-pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers?
De Tullio, Pascal ULg; Ouedraogo, R.; Becker, B. et al

in Fundamental & Clinical Pharmacology (2002)

Detailed reference viewed: 20 (4 ULg)
Full Text
Peer Reviewed
See detail2-Alkyl-3-alkylamino-2H-benzo- and pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers?
Ouedraogo, R.; Becker, B.; Boverie, S. et al

in Biological Chemistry (2002), 383

Detailed reference viewed: 8 (0 ULg)
Full Text
Peer Reviewed
See detailRelaxant effect of K+ATP channel openers on the uterine smooth muscle: pharmacological in vitro models
De Tullio, Pascal ULg; Boverie, S.; Dewalque, Daniel ULg et al

in Fundamental & Clinical Pharmacology (2002)

Detailed reference viewed: 16 (2 ULg)
Peer Reviewed
See detail2-Alkyl-3-alkylamino-2H-benzo- and pyridothiadiazine 1,1-dioxides: Ca++ channel blockers rather than K+ATP channel openers?
De Tullio, Pascal ULg; Becker, B.; Ouedraogo, R. et al

Poster (2001, December 08)

Detailed reference viewed: 6 (0 ULg)
Peer Reviewed
See detailSynthesis and pharmacological evaluation of 4,6-disubstituted 2,2-dimethylchromans structurally related to the KATP channel opener cromakalim
Sebille, S.; Becker, B.; Boverie, S. et al

Conference (2001, May)

Detailed reference viewed: 6 (3 ULg)